Versant Capital Management, Inc Genmab A/S Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Genmab A/S stock. As of the latest transaction made, Versant Capital Management, Inc holds 722 shares of GMAB stock, worth $15,501. This represents 0.0% of its overall portfolio holdings.
Number of Shares
722Holding current value
$15,501% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding GMAB
# of Institutions
239Shares Held
52.6MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY15.1MShares$325 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$109 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.42MShares$94.9 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.07MShares$65.8 Million0.44% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$49.5 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.1B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...